Histological and immunohistological findings in biliary intraepithelial neoplasia arising from a background of chronic biliary disease compared with liver cirrhosis of non-biliary aetiology

Histopathology

Volumn 59, Issue 5, 2011, Pages 867-875

  Aishima, Shinichi ^a   Iguchi, Tomohiro ^a   Fujita, Nobuhiro ^a   Taketomi, Akinobu ^a   Maehara, Yoshihiko ^a   Tsuneyoshi, Masazumi ^a   Oda, Yoshinao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Biliary dysplasia; Cell cycle; Hepatitis; Liver cirrhosis; MUC

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; KI 67 ANTIGEN; MUCIN 1; MUCIN 2; MUCIN 5AC; PROTEIN P16; PROTEIN P21;

ARTICLE; BILE DUCT; BILE DUCT CANCER; BILE DUCT STONE; BILIARY INTRAEPITHELIAL NEOPLASIA; BILIARY TRACT DISEASE; CELL PROLIFERATION; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DYSPLASIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LIVER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BILIARY TRACT DISEASES; BILIARY TRACT NEOPLASMS; CARCINOMA IN SITU; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MUCIN 5AC; NEOPLASM PROTEINS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 81555200685     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04011.x     Document Type: Article

References (28)

1. Zen Y, Adsay NV, Bardadin K et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod. Pathol. 2007; 20; 701-709.
2. Zen Y, Aishima S, Ajioka Y et al. Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement. Pathol. Int. 2005; 55; 180-188.
3. Itatsu K, Zen Y, Ohira S et al. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int. 2007; 27; 1174-1184.
4. Zen Y, Sasaki M, Fujii T et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct - an immunohistochemical study of 110 cases of hepatolithiasis. J. Hepatol. 2006; 44; 350-358.
5. Aishima S, Kuroda Y, Nishihara Y et al. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am. J. Surg. Pathol. 2007; 31; 1059-1067.
6. Donato F, Gelatti U, Tagger A et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001; 12; 959-964.
7. Torbenson M, Yeh MM, Abraham SC. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis. Am. J. Surg. Pathol. 2007; 31; 1410-1413.
8. Rougemont AL, Genevay M, McKee TA et al. Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis. Virchows Arch. 2010; 456; 711-717.
9. Wu TT, Levy M, Correa AM et al. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer 2009; 115; 4564-4575.
10. Aishima S, Nishihara Y, Tsujita E et al. Biliary neoplasia with extensive intraductal spread associated with liver cirrhosis: a hitherto unreported variant of biliary intraepithelial neoplasia. Hum. Pathol. 2008; 39; 939-947.
11. Nakanishi Y, Zen Y, Kondo S et al. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum. Pathol. 2008; 39; 1153-1161.
12. Biankin AV, Kench JG, Morey AL et al. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res. 2001; 61; 8830-8837.
13. Maitra A, Adsay NV, Argani P et al. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod. Pathol. 2003; 16; 902-912.
14. Nagata K, Horinouchi M, Saitou M et al. Mucin expression profile in pancreatic cancer and the precursor lesions. J. Hepatobiliary Pancreat. Surg. 2007; 14; 243-254.
15. Feldmann G, Beaty R, Hruban RH et al. Molecular genetics of pancreatic intraepithelial neoplasia. J. Hepatobiliary Pancreat. Surg. 2007; 14; 224-232.
16. DeHaan RD, Kipp BR, Smyrk TC et al. An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas. Hum. Pathol. 2006; 38; 491-499.
17. Taniai M, Higuchi H, Burgart LJ et al. p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. Gastroenterology 2002; 123; 1090-1098.
18. Sasaki M, Yamaguchi J, Itatsu K et al. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. J. Pathol. 2008; 215; 175-183.
19. Zen Y, Harada K, Sasaki M et al. Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. Am. J. Pathol. 2002; 161; 1475-1484.
20. Aishima S, Kuroda Y, Nishihara Y et al. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour. Histopathology 2006; 49; 35-44.
21. Perumal V, Wang J, Thuluvath P et al. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum. Pathol. 2006; 37; 1211-1216.
22. Zhou YM, Yin ZF, Yang JM et al. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J. Gastroenterol. 2008; 14; 632-635.
23. Lee TY, Lee SS, Jung SW et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am. J. Gastroenterol. 2008; 103; 1716-1720.
24. Shaib YH, El-Serag HB, Davila JA et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005; 128; 620-626.
25. Kobayashi M, Ikeda K, Saitoh S et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88; 2471-2477.
26. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J. Gastroenterol. Hepatol. 2002; 17; 1049-1055.
27. Yamamoto M, Takasaki K, Nakano M et al. Minute nodular intrahepatic cholangiocarcinoma. Cancer 1998; 82; 2145-2149.
28. Fujii T, Zen Y, Nakanuma Y. Perihilar cholangiocarcinoma arising in hepatitis C virus-related liver cirrhosis with hepatocellular carcinoma. J. Gastroenterol. 2007; 42; 698-702.